Array
(
[Ovarian Cancer] => Array
(
[Austin] => https://www.survivornet.com/austin/
[Baltimore] => https://www.survivornet.com/baltimore/
[Charlotte] => https://www.survivornet.com/charlotte/
[Cleveland] => https://www.survivornet.com/cleveland/
[Columbus] => https://www.survivornet.com/columbus/
[Dallas / Ft. Worth] => https://www.survivornet.com/dallas-ftworth/
[Denver] => https://www.survivornet.com/denver/
[Detroit] => https://www.survivornet.com/detroit/
[Indianapolis] => https://www.survivornet.com/indianapolis-ovarian-cancer/
[Louisville] => https://www.survivornet.com/louisville/
[Memphis] => https://www.survivornet.com/memphis/
[Minneapolis] => https://www.survivornet.com/minneapolis/
[Nashville] => https://www.survivornet.com/nashville/
[Phoenix] => https://www.survivornet.com/phoenix/
[Portland] => https://www.survivornet.com/portland/
[Salt Lake City] => https://www.survivornet.com/salt-lake-city/
[San Antonio] => https://www.survivornet.com/san-antonio/
[San Diego] => https://www.survivornet.com/san-diego/
[San Francisco] => https://www.survivornet.com/san-francisco/
[San Jose] => https://www.survivornet.com/san-jose/
[Seattle] => https://www.survivornet.com/seattle/
) [Multiple Myeloma] => Array
(
[Ann Arbor] => https://www.survivornet.com/ann-arbor-michigan-multiple-myeloma-treatment/
[Miami] => https://www.survivornet.com/miami-florida-multiple-myeloma-treatment/
[Phoenix] => https://www.survivornet.com/phoenix-arizona-multiple-myeloma-treatment/
) [Glioma] => Array
(
[Midwest] => https://www.survivornet.com/midwest/
[Mountain States] => https://www.survivornet.com/glioma-mountain-states/
[Southeast] => https://www.survivornet.com/southeast/
) )
A Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type Psoriasis Summary The study is designed to investigate efficacy and safety of KBL697 in patients with Moderate Plaque Type Psoriasis. KBL697 has been developed as a potential new treatment for Psoriatic Plaque.
View Eligibility Criteria Eligibility Criteria Inclusion Criteria: Male or female, aged 18 to 75 years (inclusive) Have a diagnosis of plaque type psoriasis for ≥ 6 months Must have chronic plaque type psoriasis of moderate severity All subjects must agree and commit to the use of a reliable contraceptive regimen. Exclusion Criteria: Current diagnosis of forms of psoriasis other than chronic plaque type only Drug-induced psoriasis Other inflammatory skin disease that may confound the evaluation of plaque psoriasis Failed 2 or more systemic treatments for plaque psoriasis Medicinal shampoos that contain tar and/or salicylic acid within 2 weeks prior to Baseline Visit
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 10 Locations for this study
Total Skin and Beauty Dermatology Center Birmingham Alabama, 35205, United States
Southern California Dermatology, Inc Santa Ana California, 92701, United States
Clinical Science Institute Santa Monica California, 90404, United States
Revival Research Institute Doral Florida, 33122, United States
Indago Research and Health Center Hialeah Florida, 33012, United States
Louisiana Dermatology Associates - Dermatology Baton Rouge Louisiana, 70809, United States
Premier Specialist Kogarah New South Wales, 2217, Australia
Westmead Hospital Westmead New South Wales, 2145, Australia
Veracity Clinical Trials Ltd Woolloongabba Queensland, 4102, Australia
Sinclair Dermatology East Melbourne Victoria, 3002, Australia
How clear is this clinincal trial information?
Sign Up Sign up now for access to powerful tools, top experts, and customized information to help you fight cancer.
Personalized content tailored to your profile and disease type Access exclusive patient guides Breaking treatment information and expert perspectives and more... Sign Up Now Already have an account? Sign In
Sign Up Already have an account? Sign In
Sign In Don't have an account? Sign Up
Password reset is unavailable because your account was created using 'Sign Up with Google. To continue, please use the Google sign-in button below. Don't have an account? Sign Up